Abstract: Chronic lymphocytic leukemia (CLL) is a malignancy mainly affecting elderly people and is still considered an incurable disease. Despite recent advances in CLL treatment, relapse rates are high and often accompanied by the development of resistance towards conventional chemotherapy. Thus, new agents are needed for the treatment of these patients. In recent years, our understanding of the biological mechanisms driving CLL pathogenesis has considerably improved, and novel treatment strategies are arising. This review summarizes recent insights in CLL biology and describes several new agents and treatment strategies that are currently explored in pre-clinical studies and early-phase clinical trials. ... Read more

Abstract: On a grander scale, multiple sclerosis is a battle between a patient's will to fight and the disease's vicious attack on central nerve cells. On a cellular scale, it's between the T helper 1 (Th1) cell, which attacks and destroys the myelin sheath that protects nerve cells, and the Th2 and Th3 cells, which try to bring Th1 cells under control. ... Read more

Abstract: Lupus is believed to be an autoimmune disease, affecting many more women than men. Patients develop immune responses to self DNA, omnipresent in the body. Estrogen and androgen are involved in the disease. Immunosuppression and sex hormone therapeutics are two major classes of drugs in clinical trials. ... Read more